Scientific and business development for the vaccine industry

 

World Vaccine Congress Europe

 

 

  • Delve into new technologies for vaccine development, including nanotech, synthetic biology and new-generation adjuvants
     
  • Hear clinical phase I, II and III data from leading biotechs and big pharma
     
  • Gain updates on the latest discovery-stage prophylactic and therapeutic vaccines
     
  • Explore the latest methods for improving bioprocessing and manufacturing methodologies for current and future vaccines

Download the pre-brochure

 

Should you sponsor?

Why get involved?

Find out more about how you can promote your products at the vaccines sector’s premier event by downloading the sponsorship brochure today. 

 

Why sponsor?

  • Speak to a room full of vaccine experts
  • Host a roundtable and meet your customers
  • Let us organise 1-2-1 meetings for you
  • Let us generate sales leads pre-event
  • Take a private meeting room

Why exhibit?

  • Show off your latest products & innovations
  • Promote new services
  • Educate your target market
  • Generate new sales leads
  • Raise brand profile

Get the sponsorship prospectus

Over 50 innovative companies on display

 

  • Gold Sponsor

    Retroscreen Virology at World Vaccine Congress Europe

    Bronze Sponsor

    4Clinics at World Vaccine Congress Europe
  • Bronze Sponsor

    SGS Belgium NV at World Vaccine Congress Europe

    Bronze Sponsor

    West Pharmaceutical Services at World Vaccine Congress Europe
  • Showcase Sponsor

    Lipotek Pty Ltd at World Vaccine Congress Europe

    Exhibitor

    BioKinetic Europe at World Vaccine Congress Europe
  • Exhibitor

    3M Health Care Ltd at World Vaccine Congress Europe

    Exhibitor

    Viro Cyt at World Vaccine Congress Europe
  • Exhibitor

    Union Plastic at World Vaccine Congress Europe

    Exhibitor

    F.E.F. Chemicals As at World Vaccine Congress Europe

Join them

 

Interactive Sessions Offer High Level Networking

 

World Vaccine Congress Europe

“The excellent program, the quality of the speakers and their relevance for the field. In terms of commercial opportunities, the former provides an opportunity to engage with the relevant leader.” 
ExpreS2ion Biotechnologies

World Vaccine Congress Europe

“Great networking opportunity and the level of technical talks is well targeted”
Sanofi Pasteur

World Vaccine Congress Europe

“Well organised, interesting sessions, high calibre attendees supporting good networking opportunities”
MedImmune

 

Co-located with

Be part of the conversation

 

Dr Guillaume Leroy

Exclusive interview with Dr Guillaume Leroy, Sanofi Pasteur on Dengue

With the 15th World Vaccine Congress on 7 – 9 April in Washington DC only just over a one month away, I conducted an interview ...

The post Exclusive interview with Dr Guillaume Leroy, Sanofi Pasteur on Dengue appeared first on Vaccine Nation.

advaxis

Advaxis Secures $23 Million Financing

Last week, Advaxis, Inc. (a clinical-stage biotechnology company developing cancer immunotherapies on its proprietary Lm-LLO platform technology), announced that a combined $23 million of purchase agreements ...

The post Advaxis Secures $23 Million Financing appeared first on Vaccine Nation.

o-EXPERIMENTAL-HIV-VACCINE-FAILS-facebook-1000x550

Improve your Site’s chances of getting selected for future Healthy Volunteer studies

VaccineNation welcomes ClinEdge as a guest blogger. Why isn’t your research site being considered for Healthy Volunteer Vaccine Studies? Is it your site? Is it ...

The post Improve your Site’s chances of getting selected for future Healthy Volunteer studies appeared first on Vaccine Nation.

Join the Community

Strategy and innovation in vaccines

Sign Up to Our Newsletter